31 results
Search Results
2. [Alteration of the paper-chromatography determined arginase activity in liver, serum and peritoneal washing fluid in in vivo autolysis of a liver lobe of the rat].
- Author
-
Blech W
- Subjects
- Animals, Arginase metabolism, Autolysis, Chromatography, Paper, Female, Male, Rats, Arginase analysis, Liver analysis, Peritoneal Cavity analysis
- Published
- 1967
3. [Quantitative determination of nialamide with cation exchange paper in suicidal poisoning].
- Author
-
Koźlicka-Gajdzińska H and Sybirska H
- Subjects
- Chromatography, Ion Exchange, Forensic Medicine, Humans, Male, Middle Aged, Nialamide blood, Nialamide urine, Spectrophotometry, Ultraviolet Rays, Intestine, Small analysis, Kidney analysis, Liver analysis, Nialamide analysis, Nialamide poisoning, Stomach analysis, Suicide
- Published
- 1968
4. [On the detection of dieldrin in a case of dieldrin poisoning].
- Author
-
Weinig E, Machbert G, and Zink P
- Subjects
- Adult, Chromatography, Paper, Dieldrin analysis, Humans, Male, Spectrum Analysis, Dieldrin poisoning, Liver pathology, Stomach chemistry
- Published
- 1966
5. [Bioptic studies of the liver and electrophoretic studies of serum and blister fluid in pemphigus vulgaris].
- Author
-
Banerjee BN
- Subjects
- Albumins analysis, Biopsy, Blister, Blood Protein Electrophoresis, Blood Proteins analysis, Electrophoresis, Globulins analysis, Humans, Paper, Proteins analysis, Serum Albumin analysis, Serum Globulins analysis, Exudates and Transudates analysis, Liver pathology, Pemphigus blood, Pemphigus pathology
- Published
- 1966
6. [Metabolism os steroid hormones in the cartilaginous fish Torpedo marmorata].
- Author
-
Breuer J and Breuer H
- Subjects
- Animals, Chromatography, Paper, Estrogens analysis, NAD metabolism, NADP metabolism, Adrenal Glands metabolism, Estradiol metabolism, Fishes metabolism, Liver metabolism, Steroids metabolism, Testosterone metabolism
- Published
- 1968
- Full Text
- View/download PDF
7. [Studies on the problem of hepatic involvement in tuberculosis in childhood].
- Author
-
Sitzmann FC
- Subjects
- Child, Child, Preschool, Chromatography, Paper, Humans, Infant, Isoniazid adverse effects, Keto Acids urine, Tuberculosis, Pulmonary drug therapy, Chemical and Drug Induced Liver Injury etiology, Liver physiopathology, Tuberculosis, Pulmonary physiopathology
- Published
- 1966
8. [On the metabolism of the catecholamine metabolite 3,4-dihydroxymandelic acid].
- Author
-
Thomas H
- Subjects
- Animals, Chromatography, Paper, Glyoxylates analysis, Rats, Spectrum Analysis, Aldehydes analysis, Liver metabolism, Mandelic Acids metabolism
- Published
- 1966
9. Hepatic neoplasms associated with contraceptive and anabolic steroids.
- Author
-
Ishak KG
- Subjects
- Adolescent, Adult, Aged, Carcinoma, Hepatocellular pathology, Child, Child, Preschool, Female, Humans, Hyperplasia, Liver Neoplasms pathology, Liver Regeneration, Male, Middle Aged, Anabolic Agents adverse effects, Carcinoma, Hepatocellular chemically induced, Contraceptives, Oral adverse effects, Liver pathology, Liver Neoplasms chemically induced
- Published
- 1979
- Full Text
- View/download PDF
10. A carbohydrate-reduced high-protein diet improves HbA 1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial.
- Author
-
Skytte MJ, Samkani A, Petersen AD, Thomsen MN, Astrup A, Chabanova E, Frystyk J, Holst JJ, Thomsen HS, Madsbad S, Larsen TM, Haugaard SB, and Krarup T
- Subjects
- Aged, Anthropometry, Blood Glucose metabolism, Blood Pressure, Body Weight, Cardiovascular Diseases metabolism, Cross-Over Studies, Fatty Liver, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Postprandial Period, Treatment Outcome, Adipose Tissue metabolism, Diabetes Mellitus, Type 2 diet therapy, Diabetes Mellitus, Type 2 immunology, Diet, Carbohydrate-Restricted, Diet, High-Protein, Glycated Hemoglobin analysis, Liver metabolism
- Abstract
Aims/hypothesis: Dietary recommendations for treating type 2 diabetes are unclear but a trend towards recommending a diet reduced in carbohydrate content is acknowledged. We compared a carbohydrate-reduced high-protein (CRHP) diet with an iso-energetic conventional diabetes (CD) diet to elucidate the effects on glycaemic control and selected cardiovascular risk markers during 6 weeks of full food provision of each diet., Methods: The primary outcome of the study was change in HbA
1c . Secondary outcomes reported in the present paper include glycaemic variables, ectopic fat content and 24 h blood pressure. Eligibility criteria were: men and women with type 2 diabetes, HbA1c 48-97 mmol/mol (6.5-11%), age >18 years, haemoglobin >6/>7 mmol/l (women/men) and eGFR >30 ml min-1 (1.73 m)-2 . Participants were randomised by drawing blinded ballots to 6 + 6 weeks of an iso-energetic CRHP vs CD diet in an open label, crossover design aiming at body weight stability. The CRHP/CD diets contained carbohydrate 30/50 energy per cent (E%), protein 30/17E% and fat 40/33E%, respectively. Participants underwent a meal test at the end of each diet period and glycaemic variables, lipid profiles, 24 h blood pressure and ectopic fat including liver and pancreatic fat content were assessed at baseline and at the end of each diet period. Data were collected at Copenhagen University Hospital, Bispebjerg and Copenhagen University Hospital, Herlev., Results: Twenty-eight participants completed the study. Fourteen participants carried out 6 weeks of the CRHP intervention followed by 6 weeks of the CD intervention, and 14 participants received the dietary interventions in the reverse order. Compared with a CD diet, a CRHP diet reduced the primary outcome of HbA1c (mean ± SEM: -6.2 ± 0.8 mmol/mol (-0.6 ± 0.1%) vs -0.75 ± 1.0 mmol/mol (-0.1 ± 0.1%); p < 0.001). Nine (out of 37) pre-specified secondary outcomes are reported in the present paper, of which five were significantly different between the diets, (p < 0.05); compared with a CD diet, a CRHP diet reduced the secondary outcomes (mean ± SEM or medians [interquartile range]) of fasting plasma glucose (-0.71 ± 0.20 mmol/l vs 0.03 ± 0.23 mmol/l; p < 0.05), postprandial plasma glucose AUC (9.58 ± 0.29 mmol/l × 240 min vs 11.89 ± 0.43 mmol/l × 240 min; p < 0.001) and net AUC (1.25 ± 0.20 mmol/l × 240 min vs 3.10 ± 0.25 mmol/l × 240 min; p < 0.001), hepatic fat content (-2.4% [-7.8% to -1.0%] vs 0.2% [-2.3% to 0.9%]; p < 0.01) and pancreatic fat content (-1.7% [-3.5% to 0.6%] vs 0.5% [-1.0% to 2.0%]; p < 0.05). Changes in other secondary outcomes, i.e. 24 h blood pressure and muscle-, visceral- or subcutaneous adipose tissue, did not differ between diets., Conclusions/interpretation: A moderate macronutrient shift by substituting carbohydrates with protein and fat for 6 weeks reduced HbA1c and hepatic fat content in weight stable individuals with type 2 diabetes., Trial Registration: ClinicalTrials.gov NCT02764021., Funding: The study was funded by grants from Arla Food for Health; the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; the Department of Clinical Medicine, Aarhus University; the Department of Nutrition, Exercise and Sports, University of Copenhagen; and Copenhagen University Hospital, Bispebjerg.- Published
- 2019
- Full Text
- View/download PDF
11. Modeling of the contrast-enhanced perfusion test in liver based on the multi-compartment flow in porous media.
- Author
-
Rohan E, Lukeš V, and Jonášová A
- Subjects
- Computer Simulation, Contrast Media pharmacokinetics, Finite Element Analysis, Humans, Imaging, Three-Dimensional statistics & numerical data, Mathematical Concepts, Models, Biological, Porosity, Liver blood supply, Liver diagnostic imaging, Liver Circulation physiology, Radiographic Image Enhancement methods, Tomography, X-Ray Computed statistics & numerical data
- Abstract
The paper deals with modeling the liver perfusion intended to improve quantitative analysis of the tissue scans provided by the contrast-enhanced computed tomography (CT). For this purpose, we developed a model of dynamic transport of the contrast fluid through the hierarchies of the perfusion trees. Conceptually, computed time-space distributions of the so-called tissue density can be compared with the measured data obtained from CT; such a modeling feedback can be used for model parameter identification. The blood flow is characterized at several scales for which different models are used. Flows in upper hierarchies represented by larger branching vessels are described using simple 1D models based on the Bernoulli equation extended by correction terms to respect the local pressure losses. To describe flows in smaller vessels and in the tissue parenchyma, we propose a 3D continuum model of porous medium defined in terms of hierarchically matched compartments characterized by hydraulic permeabilities. The 1D models corresponding to the portal and hepatic veins are coupled with the 3D model through point sources, or sinks. The contrast fluid saturation is governed by transport equations adapted for the 1D and 3D flow models. The complex perfusion model has been implemented using the finite element and finite volume methods. We report numerical examples computed for anatomically relevant geometries of the liver organ and of the principal vascular trees. The simulated tissue density corresponding to the CT examination output reflects a pathology modeled as a localized permeability deficiency.
- Published
- 2018
- Full Text
- View/download PDF
12. Study on the in vitro effects of the mixtures of polycyclic aromatic hydrocarbons (PAHs) and heavy metals on ethoxyresorufin-O-deethylase (EROD) activity in Mossambica tilapia liver.
- Author
-
Han da X, Wang HY, Yue HW, and Wang SM
- Subjects
- Animals, Liver drug effects, Tilapia physiology, Cytochrome P-450 CYP1A1 metabolism, Liver enzymology, Metals, Heavy toxicity, Polycyclic Aromatic Hydrocarbons toxicity, Water Pollutants, Chemical toxicity
- Abstract
This paper reports in vitro effects of individual heavy metals (Cd(2+), Cu(2+) and Hg(2+)), and PAHs, including benzo[a]pyrene(BaP), indeno[1,2,3-cd]pyrene (IP) and fluoranthene (FL), and their mixtures on ethoxyresorufin-O-deethylase (EROD) activities using a plate-reader method. The results showed that all three metals inhibited EROD activity, while BaP/IP significantly induced the enzyme. However, FL alone decreased EROD activity. Moreover, co-treatment with BaP/IP and heavy metals inhibited PAH-induced EROD activities, while combined exposure to FL and heavy metals induced FL-inhibited EROD activities.
- Published
- 2013
- Full Text
- View/download PDF
13. [Perfusion computed tomography for diffuse liver diseases].
- Author
-
Schmidt SA and Juchems MS
- Subjects
- Humans, Liver diagnostic imaging, Liver Diseases diagnostic imaging, Perfusion Imaging methods, Radiographic Image Enhancement methods, Tomography, X-Ray Computed methods
- Abstract
Clinical/methodical Issue: Perfusion computed tomography (CT) has its main application in the clinical routine diagnosis of neuroradiological problems., Standard Radiological Methods: Polyphase multi-detector spiral computed tomography is primarily used in liver diagnostics., Methodical Innovations: The use of perfusion CT is also possible for the diagnostics and differentiation of diffuse hepatic diseases., Performance: The differentiation between cirrhosis and cirrhosis-like parenchymal changes is possible. It also helps to detect early stages of malignant tumors., Achievements: However, there are some negative aspects, particularly that of radiation exposure., Practical Recommendations: This paper summarizes the technical basics and possible applications of perfusion CT in cases of diffuse liver disease and weighs up the advantages and disadvantages of the examinations.
- Published
- 2012
- Full Text
- View/download PDF
14. Comparison of hepatic and nephric total mercury concentrations between feral and ranch American mink (Neovison vison) from northwestern Poland.
- Author
-
Kalisinska E, Budis H, Lanocha N, Podlasinska J, Jedrzejewska E, and Kosik-Bogacka DI
- Subjects
- Animal Husbandry, Animals, Environmental Pollution statistics & numerical data, Poland, Environmental Monitoring methods, Environmental Pollutants metabolism, Kidney metabolism, Liver metabolism, Mercury metabolism, Mink metabolism
- Abstract
For many years the American mink (Neovison vison) has been used in North America (where it originates from) as a sensitive indirect bioindicator in assessing the degree of mercury (Hg) contamination in terrestrial ecosystems. The aim of this paper was the determination of total concentrations of Hg in the liver and kidneys of feral and ranch mink from the Warta Mouth National Park (WMNP) and from farms located in northwestern Poland, for comparison with similar data on American mink from North America. In road-killed feral mink from the WMNP, the mean concentrations were 11.8 and 14.1 mg/kg dry weight in the liver and kidney, respectively. Mean Hg concentrations in feral mink were from 240 to 90 times higher in these two respective tissues than in ranch mink. The feral mink from northwestern Poland had concentrations of hepatic and nephric Hg similar to the highest concentrations that have been recorded over the past several decades in wild American mink from certain areas of Canada and the USA.
- Published
- 2012
- Full Text
- View/download PDF
15. Liver segmentation using sparse 3D prior models with optimal data support.
- Author
-
Florin C, Paragios N, Funka-Lea G, and Williams J
- Subjects
- Artificial Intelligence, Computer Simulation, Databases, Factual, Humans, Information Storage and Retrieval methods, Radiographic Image Enhancement methods, Reproducibility of Results, Sensitivity and Specificity, Algorithms, Imaging, Three-Dimensional methods, Liver diagnostic imaging, Models, Biological, Pattern Recognition, Automated methods, Radiographic Image Interpretation, Computer-Assisted methods, Tomography, X-Ray Computed methods
- Abstract
Volume segmentation is a relatively slow process and, in certain circumstances, the enormous amount of prior knowledge available is underused. Model-based liver segmentation suffers from the large shape variability of this organ, and from structures of similar appearance that juxtapose the liver. The technique presented in this paper is devoted to combine a statistical analysis of the data with a reconstruction model from sparse information: only the most reliable information in the image is used, and the rest of the liver's shape is inferred from the model and the sparse observation. The resulting process is more efficient than standard segmentation since most of the workload is concentrated on the critical points, but also more robust, since the interpolated volume is consistent with the prior knowledge statistics. The experimental results on liver datasets prove the sparse information model has the same potential as PCA, if not better, to represent the shape of the liver. Furthermore, the performance assessment from measurement statistics on the liver's volume, distance between reconstructed surfaces and ground truth, and inter-observer variability demonstrates the liver is efficiently segmented using sparse information.
- Published
- 2007
- Full Text
- View/download PDF
16. Design of robust vascular tree matching: validation on liver.
- Author
-
Charnoz A, Agnus V, Malandain G, Nicolau S, Tajine M, and Soler L
- Subjects
- Algorithms, Artificial Intelligence, Humans, Imaging, Three-Dimensional methods, Radiographic Image Enhancement methods, Reproducibility of Results, Sensitivity and Specificity, Hepatic Artery diagnostic imaging, Liver blood supply, Liver diagnostic imaging, Pattern Recognition, Automated methods, Radiographic Image Interpretation, Computer-Assisted methods, Subtraction Technique, Tomography, X-Ray Computed methods
- Abstract
In this paper, we propose an original and efficient tree matching algorithm for intra-patient hepatic vascular system registration. Vascular systems are segmented from CT-scan images acquired at different times, and then modeled as trees. The goal of this algorithm is to find common bifurcations (nodes) and vessels (edges) in both trees. Starting from the tree root, edges and nodes are iteratively matched. The algorithm works on a set of match solutions that are updated to keep the best matches thanks to a quality criterion. It is robust against topological modifications due to segmentation failures and against strong deformations. Finally, this algorithm is validated on a large synthetic database containing cases with various deformation and segmentation problems.
- Published
- 2005
- Full Text
- View/download PDF
17. Characterization of the bile acid sensitive methotrexate carrier of rat liver cells.
- Author
-
Honscha W and Petzinger E
- Subjects
- Animals, Buffers, Cell Line, Cell Membrane metabolism, Cells, Cultured, Folate Receptors, GPI-Anchored, Folic Acid analogs & derivatives, Folic Acid pharmacology, Kinetics, Liver drug effects, Male, Methotrexate metabolism, Oligomycins, Rats, Rats, Wistar, Sodium Chloride, Sulfobromophthalein pharmacology, Tetrahydrofolates pharmacology, Tritium, Xenobiotics pharmacology, Bile Acids and Salts pharmacology, Carrier Proteins antagonists & inhibitors, Liver metabolism, Receptors, Cell Surface
- Abstract
The chemotherapeutic agent methotrexate is widely used in tumor therapy for different forms of leukemia and for the therapy of arthritis. Methotrexate is eliminated from systemic blood circulation by the liver and its transport into hepatocytes is therefore described in detail in this paper. Methotrexate uptake is energy- and sodium-dependent. The Km and the Vmax are 23 microM and 36 pmol/mg protein min, respectively. The apparent activation energy (E(app)) of methotrexate uptake (5 microM [3H]methotrexate) is 53.73 kJ/mol, which indicates an energy-dependent carrier-mediated process. Although methotrexate is a folate derivative, folate itself does not inhibit methotrexate uptake, whereas the reduced folates, dihydrofolate and tetrahydrofolate are weak uncompetitive inhibitors. In contrast, the bile acids taurocholate and cholate are effective competitive inhibitors of methotrexate uptake into hepatocytes. Further strong inhibitors are the loop diuretic bumetanide, the mycotoxin ochratoxin A and bromosulfophthalein. Because tumor patients develop drug resistance during methotrexate therapy, the uptake of methotrexate was tested in different hepatoma cell lines. In HepG2-cells and Reuber hepatoma Fao-cells the transport was non-existent or very small. However, the hepatocytoma fusion cell line HPCT-1E3, a hybrid cell line between primary rat hepatocytes and rat Reuber Fao-cells, shows an intermediate transport activity with a threefold increase of the methotrexate uptake. These results indicate the presence of a bile acid sensitive methotrexate carrier in hepatocytes which is absent in dedifferentiated hepatoma cells. The carrier differs from previously described transporters for the uptake of organic anions.
- Published
- 1999
- Full Text
- View/download PDF
18. Asymptomatic membranous obstruction of the inferior vena cava due to large intrahepatic collaterals.
- Author
-
Akaki S, Kanazawa S, Gochi A, Nakamura K, Yasui K, Togami I, Hiraki Y, and Hamazaki K
- Subjects
- Aged, Budd-Chiari Syndrome etiology, Constriction, Pathologic diagnostic imaging, Constriction, Pathologic etiology, Constriction, Pathologic physiopathology, Humans, Liver Circulation physiology, Male, Radiography, Collateral Circulation physiology, Hepatic Veins physiopathology, Liver blood supply, Vena Cava, Inferior
- Abstract
This paper presents a case of asymptomatic membranous obstruction of the inferior vena cava with a rare hemodynamic pattern consisting of large intrahepatic venous connections between the right inframembranous and the middle supramembranous hepatic vein. These remarkably large collaterals obviated significant enlargement of the azygous venous system and the development of a Budd-Chiari syndrome.
- Published
- 1995
- Full Text
- View/download PDF
19. Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. I. Tracer purification, in vitro and in vivo long-term stability, in vitro validation and biodistribution.
- Author
-
Leitha T, Hermann M, Hüttinger M, Angelberger P, and Dudczak R
- Subjects
- Animals, Drug Stability, Female, Humans, Male, Rabbits, Radionuclide Imaging, Tissue Distribution, Lipoproteins, LDL pharmacokinetics, Liver diagnostic imaging, Organotechnetium Compounds pharmacokinetics, Receptors, LDL metabolism
- Abstract
The goal of the present study was to optimize technetium-99m labelling of low-density lipoprotein (LDL) and to investigate the in vitro and in vivo properties of the tracer to determine whether its application for quantitative scintigraphy of hepatic LDL receptor activity is feasible. LDL labelled with iodine-125 by the iodine monochloride method was used as a reference tracer. Comparison of different assessments of radiochemical purity [trichloro-acetic acid precipitation (%ppTCA), paper chromatography, size-exclusion chromatography and chloroform-methanol extraction] exhibited %ppTCA to be superior as a parameter of tracer quality. In spite of a high radiochemical purity immediately after labelling, modifications of 99mTc labelling of LDL did not overcome the poor long-term stability of the tracer. Subsequent dialysis in phosphate buffer over about 3 h sufficiently increased the long-term stability in vitro and in vivo. The competitive recognition of dialysed 99mTc-LDL and 125I-LDL with native LDL by high-affinity binding sites was demonstrated in human hepatoma cells (HepG2) and human fibroblasts. Biodistribution data of simultaneously injected 99mTc-LDL and 125I-LDL in New Zealand White rabbits showed a high uptake of both tracers in tissues with high LDL receptor activity, yet 99mTc-LDL uptake exceeded 125I-LDL uptake by two- to sevenfold. In contrast to 125I-LDL, 99mTc-LDL showed a higher unspecific uptake into the bone marrow and the spleen, suggesting an additional uptake mechanism probably via the scavenger pathway.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1993
- Full Text
- View/download PDF
20. Erythropoiesis in long term cultures of foetal liver cells is transiently obtained on adult but not on foetal adherent cell layers.
- Author
-
Royet J, Oddos T, Grasset MF, and Blanchet JP
- Subjects
- Anemia pathology, Animals, Cell Adhesion, Cell Communication, Cells, Cultured, Erythroid Precursor Cells pathology, Female, Liver cytology, Male, Mice, Mice, Inbred C57BL embryology, Mice, Mutant Strains, Organ Specificity, Pregnancy, Bone Marrow Cells, Erythroid Precursor Cells cytology, Liver embryology, Polycythemia
- Abstract
We have previously reported long term erythroid differentiation of adult bone marrow cells seeded onto adherent cells derived from adult bone marrow. In this paper, we show that the adherent cells obtained from foetal liver do not support the erythroid differentiation of either adult bone marrow cells or foetal liver cells. Adherent layers derived from bone marrow of adult W/Wv mice supported differentiation of adult bone marrow precursors, but foetal liver progenitors only produced erythrocytes for a few weeks and the foetal origin of these red cells was confirmed by haemoglobin typing. The duration and extent of erythropoiesis was generally inversely proportional to the cell dose. Foetal progenitors were as sensitive to erythropoietin as adult cells, but were optimally stimulated at a lower plateau concentration. These results suggest that inhibitory cells present in foetal liver may block erythropoiesis and their growing importance with age may provide an explanation for the arrest of erythropoiesis in the liver at late developmental stages.
- Published
- 1992
21. Salbutamol identification in liver and urine by high-performance thin-layer chromatography and densitometry.
- Author
-
De Groof J, Degroodt JM, Wyhowski de Bukanski B, and Beernaert H
- Subjects
- Albuterol isolation & purification, Albuterol urine, Chromatography, Thin Layer, Densitometry, Humans, Molecular Structure, Albuterol analysis, Liver chemistry
- Abstract
This paper describes a rapid method for the identification of salbutamol in liver and urine. Salbutamol is extracted from liver with an acid solution, purified on Baker columns and eluted with methanol. After derivatization, salbutamol is detected on HPTLC plates as a blue spot. Urine samples are directly purified on the C18 columns and then the same procedure is followed as for the liver samples. Using this screening method, salbutamol can be semi-quantitatively determined at the micrograms/kg level.
- Published
- 1991
- Full Text
- View/download PDF
22. Competitive inhibition of the uptake of demethylphalloin by cholic acid in isolated hepatocytes. Evidence for a transport competition rather than a binding competition.
- Author
-
Petzinger E
- Subjects
- Animals, Binding, Competitive, Biological Transport drug effects, Cholic Acids metabolism, In Vitro Techniques, Kinetics, Liver cytology, Liver drug effects, Rats, Alkaloids metabolism, Cholic Acids pharmacology, Liver metabolism
- Abstract
Cholic acid inhibits the uptake of demethylphalloin (DMP), in a competitive manner. The bile acid increases the Michaelis constant but not Vmax of the inward transport. The inhibition constant Ki for cholate was found to be 8 microM. Cholate competes for the transport system but not for intracellular binding of phallotoxins. Various experimental data presented in this paper exclude an accumulation of phallotoxins in hepatocytes by intracellular binding only. Preincubation of hepatocytes with small concentration of either (3H)-demethylphalloin or (14C)-cholate and subsequent treatment with high concentrations of the non-labelled compounds reduces the intracellular concentration of both radioactive substrates. In accordance with earlier findings the above results suggest a common component needed for the transport of both phallotoxins and cholic acid.
- Published
- 1981
- Full Text
- View/download PDF
23. In vitro studies on the interaction between bile salts and key enzymes of the liver.
- Author
-
Schmidt K, Schölmerich J, Ritter H, and Schmitt J
- Subjects
- Alanine Transaminase metabolism, Aspartate Aminotransferases metabolism, Enzyme Inhibitors, Humans, L-Lactate Dehydrogenase metabolism, Bile Acids and Salts physiology, Cholestasis metabolism, Liver enzymology
- Abstract
Interactions between bile salts and cellular constituents are of considerable significance in studies on cholestasis. The main points of interest are the effects of the various bile salts on lipid and protein structures. Of primary interest are the interactions with lipids since these can cause disorder in cellular metabolism by eliminating compartmentalization. Conformational changes of proteins can occur through interactions with bile salts. They can involve specific functions. Of special importance here are the enzymes, since these are decisive supportive agents in cellular processes. In this paper, the effect of various bile salts on the activity of key hepatic enzymes was studied. In addition to the kinetic tests for enzyme activity, structural changes of the enzymes were studied as well using electrophoretic techniques. It could be shown that even much lower bile salt concentrations than those which occur in bile can lead to a complete inhibition of activity. The varying sensitivities of different enzymes when they react in the presence of bile salts is striking. According to the degree of hydroxylation, the various bile salts show characteristic differences in inhibitory effect on enzymatic activity. On the basis of the results reported here, it is quite possible that the interaction between bile salts and enzymes is a participating factor in the etiology and pathogenesis of cholestatic hepatic changes.
- Published
- 1982
- Full Text
- View/download PDF
24. Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment.
- Author
-
Teunissen MW, Willemse PH, Sleijfer DT, Sluiter WJ, and Breimer DD
- Subjects
- Adolescent, Adult, Antineoplastic Agents pharmacology, Antineoplastic Combined Chemotherapy Protocols, Bleomycin pharmacology, Cisplatin pharmacology, Humans, Kidney metabolism, Male, Metabolic Clearance Rate, Vinblastine pharmacology, Antipyrine metabolism, Liver metabolism, Testicular Neoplasms metabolism
- Abstract
Antipyrine plasma clearance and rates of metabolite formation were measured on four occasions in eight patients with disseminated nonseminomatous testicular cancer. Antipyrine tests were performed before, during (2X), and after treatment with a combination of cisplatin (P), vinblastin (V), and bleomycin (B). Pretreatment values were compared with a male control group (n = 14) matched for age and body weight. Antipyrine plasma clearance was 20% higher in patients with testicular cancer (first experiment) than in the control group. This difference was mainly due to a 35% higher clearance for production of 3-hydroxymethylantipyrine (HMA), while clearance for production of norantipyrine (NORA) and 4-hydroxyantipyrine (OHA) was not significantly different from the control group. A reduction in CLHMA was observed after complete remission (fourth experiment), indicating that the presence of the tumor may be related to a selective increase of HMA formation. Treatment with the PVB combination resulted in a 30% increase in antipyrine plasma clearance (second and third experiments), whereas the rates of formation of the main metabolites of antipyrine were all increased to the same extent. These accelerating effects of PVB treatment persisted for at least 6 weeks after the start of the last treatment cycle. The data presented in this paper demonstrate that the presence of a testicular tumor and the use of cytostatics can have an accelerating and partially selective effect on oxidative drug-metabolizing enzyme activity in man.
- Published
- 1984
- Full Text
- View/download PDF
25. A semiempirical model used to obtain values for scintiphoto contrast caused by spherical lesions arbitrarily located within the liver.
- Author
-
Green TO
- Subjects
- Humans, Mathematics, Radionuclide Imaging, Liver diagnostic imaging, Liver Diseases diagnostic imaging, Models, Biological
- Abstract
This paper reports a simple model for calculation of maximal scintiphoto contrast caused by a spherical cold or hot lesion located in an arbitrary position inside an organ with uniformly distributed radioactivity. By applying this model, equidetection curves were constructed for cross sections through the liver. Comparison of equidetection curves obtained for different camera views enabled determination of the view to be selected for the best visualization of a given lesion. The minimum size of a cold lesion that can be detected without regard to the location in the liver in 3.0 cm diameter using anterior, right oblique anterior, right lateral, and posterior views. 99mTc is found to be a more suitable radionuclide for liver scintigraphy than 113mIn.
- Published
- 1978
- Full Text
- View/download PDF
26. Inhibition of 3H-demethylphalloin uptake in isolated rat hepatocytes under various experimental conditions.
- Author
-
Petzinger E, Ziegler K, and Frimmer M
- Subjects
- Alkaloids, Animals, Carbon Tetrachloride pharmacology, In Vitro Techniques, Liver drug effects, Liver Neoplasms, Experimental metabolism, Liver Regeneration, Rats, Time Factors, Liver metabolism, Peptides, Cyclic metabolism
- Abstract
3H-Demethylphalloin (3H-DMP) a cyclopeptide very similar to phalloidin is taken up by isolated hepatocytes in vitro. Hepatocytes prepared from newborn animals are less sensitive to phalloidin. Their uptake of 3H-DMP is about one tenth of that of cells from adult animals. Ascites hepatoma cells, known to be insensitive to phalloidin took up negligible amounts of 3H-DMP. Cells prepared from regenerating livers took up insignificantly lower amounts of the toxin than in hepatocytes from adult animals. Treatment of hepatocytes with low concentrations of trypsin was found to switch off the phalloidin sensitivity in a reversible manner. This inhibition is due to a reduced uptake of 3H-DMP. Pretreatment of animals with CCl4, known to reduce the sensitivity to phalloidin, also decreases the uptake of 3H-DMP in isolated hepatocytes. Various agents, drugs and reagents were found to inhibit the response of isolated hepatocytes to phalloidin. All these compounds (bile acids, rifampicin, silybin, DIDS, glutardialdehyde, bromosulphophthalein, fusidic acid, antamanide, novobiocin) inhibit also the uptake of 3H-DMP in isolated hepatocytes. The results confirm our working hypothesis, presented in several previous papers, that decreased sensitivity to phalloidin is probably due to a reduced or blocked uptake of the toxin.
- Published
- 1979
- Full Text
- View/download PDF
27. Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the Scientific Committee on Consumer Safety between 2009 and 2019
- Author
-
Vera Rogiers, Mathieu Vinken, Tamara Vanhaecke, Christophe Debruyne, Emma Gustafson, Olga De Troyer, Pharmaceutical and Pharmacological Sciences, Faculty of Medicine and Pharmacy, Experimental in vitro toxicology and dermato-cosmetology, Informatics and Applied Informatics, Web and Information System Engineering, Vriendenkring VUB, Connexin Signalling Research Group, and Liver Connexin and Pannexin Research Group
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Time Factors ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,Administration, Oral ,Cosmetics ,Toxicology ,Kidney ,Consumer safety ,Safety evaluation ,Risk Assessment ,Regulatory Toxicology ,03 medical and health sciences ,Cholestasis ,Oral administration ,Toxicity Tests ,medicine ,Animals ,Humans ,European Union ,Animal testing ,Intensive care medicine ,media_common ,Alternative methods ,Toxicity data ,030102 biochemistry & molecular biology ,business.industry ,General Medicine ,Chemical Safety ,Repeated dose toxicity ,medicine.disease ,030104 developmental biology ,Liver ,Consumer Product Safety ,Toxicity ,business ,Spleen - Abstract
A focal point in the safety evaluation of cosmetic ingredients includes oral repeated dose toxicity testing, which is intended to address the most complex human endpoints. Seven years after the full implementation of the animal testing ban for cosmetic ingredients in the EU, there are still no alternative methods available capable of fully replacing oral repeated dose toxicity testing. Until this issue is resolved, the development of new cosmetic ingredients remains seriously hampered. The present paper describes a thorough screening of the oral repeated dose toxicity data included in safety evaluation reports of cosmetic ingredients addressed in the Annexes of the Cosmetics Regulation (EC) No 1223/2009, issued by the Scientific Committee on Consumer Safety between 2009 and 2019. The liver and the haematological system were identified as the potentially most frequently affected organs upon oral administration of cosmetic ingredients to animals. Evaluation of altered biochemical, morphological, and histopathological parameters related to hepatotoxicity indicated that the most recurrent events are liver weight changes, elevated liver enzymes, and alterations in serum cholesterol and bilirubin levels. Combined listing of affected parameters associated with steatosis and cholestasis indicated the possible occurrence of cholestasis, provoked by a limited number of cosmetic ingredients. The most frequently affected parameters related to the haematological system were indicative of anaemia. An in-depth analysis allowed characterisation of both regenerative and non-regenerative anaemia, pointing to direct and indirect haematotoxicity, respectively. The results presented in this study call for prioritisation of research targeted towards the development of new approach methodologies fit for animal-free repeated dose toxicity evaluation of cosmetic ingredients. Electronic supplementary material The online version of this article (10.1007/s00204-020-02868-2) contains supplementary material, which is available to authorized users.
- Published
- 2020
28. Mechanisms and in vitro models of drug-induced cholestasis
- Author
-
Pieter Annaert, Hartmut Jaeschke, Vânia Vilas-Boas, Eva Gijbels, Neel Deferm, Mathieu Vinken, Lindsey Devisscher, Pharmaceutical and Pharmacological Sciences, Faculty of Medicine and Pharmacy, Experimental in vitro toxicology and dermato-cosmetology, Liver Connexin and Pannexin Research Group, and Connexin Signalling Research Group
- Subjects
0301 basic medicine ,Drug-Related Side Effects and Adverse Reactions ,Liver toxicity ,medicine.drug_class ,Health, Toxicology and Mutagenesis ,In Vitro Techniques ,010501 environmental sciences ,Pharmacology ,liver ,Toxicology ,01 natural sciences ,MECHANISMS ,Bile Acids and Salts ,03 medical and health sciences ,Cholestasis ,drug-induced cholestasis ,In vivo ,medicine ,Animals ,Humans ,Drug induced cholestasis ,0105 earth and related environmental sciences ,in vitro models ,Liver injury ,Bile acid ,business.industry ,General Medicine ,medicine.disease ,In vitro ,030104 developmental biology ,Cell culture ,Chemical and Drug Induced Liver Injury ,business - Abstract
Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-induced cholestatic liver toxicity is a complex process, as it can be triggered by a variety of factors that induce 2 types of biological responses, namely a deteriorative response, caused by bile acid accumulation, and an adaptive response, aimed at removing the accumulated bile acids. Several key events in both types of responses have been characterized in the past few years. In parallel, many efforts have focused on the development and further optimization of experimental cell culture models to predict the occurrence of drug-induced cholestatic liver toxicity in vivo. In this paper, a state-of-the-art overview of mechanisms and in vitro models of drug-induced cholestatic liver injury is provided.
- Published
- 2019
29. A cable-driven parallel manipulator with force sensing capabilities for high-accuracy tissue endomicroscopy
- Author
-
Timo J. C. Oude Vrielink, Kiyoteru Miyashita, and George P. Mylonas
- Subjects
FOS: Computer and information sciences ,0209 industrial biotechnology ,Technology ,Microsurgery ,Computer science ,02 engineering and technology ,CONFOCAL LASER ENDOMICROSCOPY ,020901 industrial engineering & automation ,Engineering ,Endomicroscopy ,Robotic Surgical Procedures ,Computer vision ,Haptic technology ,Microscopy ,Palpation ,Radiology, Nuclear Medicine & Medical Imaging ,Parallel manipulator ,General Medicine ,Equipment Design ,Surgical Instruments ,Computer Graphics and Computer-Aided Design ,Computer Science Applications ,Nuclear Medicine & Medical Imaging ,Liver ,Surgical instrument ,Cable driven ,Original Article ,Computer Vision and Pattern Recognition ,Robotics (cs.RO) ,Life Sciences & Biomedicine ,Cable-driven parallel mechanisms ,cs.RO ,0206 medical engineering ,Biomedical Engineering ,Health Informatics ,Autonomous scanning ,Contact force ,Feedback ,Computer Science - Robotics ,Image acquisition ,Animals ,Radiology, Nuclear Medicine and imaging ,Sensitivity (control systems) ,Engineering, Biomedical ,Mechanical Phenomena ,Science & Technology ,business.industry ,Endoscopy ,1103 Clinical Sciences ,Force sensing ,020601 biomedical engineering ,Surgery ,Cattle ,Artificial intelligence ,business - Abstract
This paper introduces a new surgical end-effector probe, which allows to accurately apply a contact force on a tissue, while at the same time allowing for high resolution and highly repeatable probe movement. These are achieved by implementing a cable-driven parallel manipulator arrangement, which is deployed at the distal-end of a robotic instrument. The combination of the offered qualities can be advantageous in several ways, with possible applications including: large area endomicroscopy and multi-spectral imaging, micro-surgery, tissue palpation, safe energy-based and conventional tissue resection. To demonstrate the concept and its adaptability, the probe is integrated with a modified da Vinci robot instrument., Submitted to IPCAI 2018 (The 9th International Conference on Information Processing in Computer-Assisted Interventions), 13 Pages, 12 Figures
- Published
- 2018
30. Experimental models of liver fibrosis
- Author
-
Claudia P. Oliveira, Isabelle Leclercq, Bert Van Den Bossche, Michaël Maes, Isabelle Colle, Bruno Cogliati, Wellington Andraus, Joost Willebrords, Venâncio Avancini Ferreira Alves, Sara Crespo Yanguas, Mathieu Vinken, Toxicology, Dermato-cosmetology and Pharmacognosy, Pharmaceutical and Pharmacological Sciences, Faculty of Medicine and Pharmacy, Connexin Signalling Research Group, Liver Connexin and Pannexin Research Group, and Experimental in vitro toxicology and dermato-cosmetology
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Cirrhosis ,Health, Toxicology and Mutagenesis ,Mice, Transgenic ,Disease ,In Vitro Techniques ,Toxicology ,Liver Cirrhosis, Experimental ,Article ,FÍGADO (PATOLOGIA) ,03 medical and health sciences ,In vivo ,medicine ,Hepatic Stellate Cells ,Animals ,Humans ,Genetic Predisposition to Disease ,Cells, Cultured ,liver fibrosis ,in vitro models ,hepatic stellate cell ,Wound Healing ,business.industry ,General Medicine ,medicine.disease ,animals models ,Coculture Techniques ,030104 developmental biology ,Phenotype ,Liver ,Hepatocellular carcinoma ,Hepatic stellate cell ,Steatohepatitis ,Hepatic fibrosis ,business ,Wound healing ,Signal Transduction - Abstract
Hepatic fibrosis is a wound healing response to insults and as such affects the entire world population. In industrialized countries, the main causes of liver fibrosis include alcohol abuse, chronic hepatitis virus infection and non-alcoholic steatohepatitis. A central event in liver fibrosis is the activation of hepatic stellate cells, which is triggered by a plethora of signaling pathways. Liver fibrosis can progress into more severe stages, known as cirrhosis, when liver acini are substituted by nodules, and further to hepatocellular carcinoma. Considerable efforts are currently devoted to liver fibrosis research, not only with the goal of further elucidating the molecular mechanisms that drive this disease, but equally in view of establishing effective diagnostic and therapeutic strategies. The present paper provides a state-of-the-art overview of in vivo and in vitro models used in the field of experimental liver fibrosis research.
- Published
- 2016
31. MicroRNAs as key regulators of xenobiotic biotransformation and drug response
- Author
-
Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Mathieu Vinken, Robim Marcelino Rodrigues, Jennifer Bolleyn, Experimental in vitro toxicology and dermato-cosmetology, Toxicology, Dermato-cosmetology and Pharmacognosy, and Pharmaceutical and Pharmacological Sciences
- Subjects
cytochrome P450 enzymes ,Drug-Related Side Effects and Adverse Reactions ,Health, Toxicology and Mutagenesis ,Receptors, Cytoplasmic and Nuclear ,drug transporters ,Biology ,Toxicology ,Xenobiotics ,Biological pathway ,microRNA ,Transcriptional regulation ,Animals ,Humans ,RNA, Messenger ,Gene ,Transcription factor ,General Medicine ,drug metabolism ,MicroRNAs ,Biochemistry ,Nuclear receptor ,Gene Expression Regulation ,Liver ,Pharmaceutical Preparations ,Efflux ,Drug metabolism ,Transcription Factors - Abstract
In the last decade, microRNAs have emerged as key factors that negatively regulate mRNA expression. It has been estimated that more than 50% of protein-coding genes are under microRNA control and each microRNA is predicted to repress several mRNA targets. In this respect, it is recognized that microRNAs play a vital role in various cellular and molecular processes and that, depending on the biological pathways in which they intervene, distorted expression of miRNAs can have serious consequences. It has recently been shown that specific miRNA species are also correlated with toxic responses induced by xenobiotics. Since the latter is primarily linked to the extent of detoxification in the liver accomplished by phase I and phase II biotransformation enzymes and influx and efflux drug transporters, the regulation of the mRNA levels of this particular set of genes through microRNAs is of great importance for the overall toxicological outcome. Consequently, in this paper, an overview of the current knowledge with respect to the complex interplay between microRNAs and the expression of biotransformation enzymes and drug transporters in the liver is provided. Nuclear receptors and transcription factors known to be involved in the transcriptional regulation of these genes are also discussed.
- Published
- 2015
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.